[Ropivacaine infiltration during breast cancer surgery: postoperative acute and chronic pain effect].
OBJECTIVE
Decrease acute pain after breast cancer surgery by an infiltration of ropivacaine. Analyse effect on chronic pain.


METHODS
Prospective randomised double blind versus placebo study.


METHODS
Eighty-one patients randomised between two groups received wound infiltration with 40 ml of ropivacaine 4.75 mg/ml or placebo. Acute pain was assessed during 24h with analogical visual scale and antalgic consumption. One year later, telephonic interviews looked for chronic pain and evaluate it with McGill Pain Questionnaire.


RESULTS
Analogical visual scale pain score, antalgic consumption and chronic pain incidence were similar between groups.


CONCLUSIONS
Ropivacaine scar infiltration provided no acute or chronic pain relief after breast cancer surgery.
Baudry
G
G
Pôle d'anesthésie-réanimation chirurgicale, centre hospitalier universitaire Jean-Minjoz, université de Franche-Comté, 3, boulevard Alexander-Fleming, 25000 Besançon, France. gerald.baudry@wanadoo.fr
Steghens
A
A
Laplaza
D
D
Koeberle
P
P
Bachour
K
K
Bettinger
G
G
Combier
F
F
Samain
E
E
D000208:Acute Disease; D000577:Amides / Q000008:administration & dosage*; D000772:Anesthesia, Local; D000779:Anesthetics, Local / Q000008:administration & dosage*; D001943:Breast Neoplasms / Q000601:surgery*; D002908:Chronic Disease; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010149:Postoperative Pain / Q000517:prevention & control*; D011446:Prospective Studies; D000077212:Ropivacaine; D011795:Surveys and Questionnaires
D000577:Amides; D000779:Anesthetics, Local; D000077212:Ropivacaine